C07D 291/02
Not condensed with other rings
Official title: not condensed with other rings
C07D291/02 (Not condensed with other rings) appears on 176 US grants and 165 published applications in this corpus.
Search patents in C07D- Granted patents
- 176
- Published applications
- 165
- Assignees
- 103
- Inventors
- 404
- Latest grant
- 28 Apr 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 6 | 0 |
| 1977 | 1 | 0 |
| 1978 | 1 | 0 |
| 1979 | 1 | 0 |
| 1980 | 1 | 0 |
| 1981 | 2 | 0 |
| 1982 | 2 | 0 |
| 1983 | 1 | 0 |
| 1984 | 0 | 0 |
| 1985 | 1 | 0 |
| 1986 | 5 | 0 |
| 1987 | 3 | 0 |
| 1988 | 1 | 0 |
| 1989 | 3 | 0 |
| 1990 | 6 | 0 |
| 1991 | 1 | 0 |
| 1992 | 3 | 0 |
| 1993 | 2 | 0 |
| 1994 | 1 | 0 |
| 1995 | 2 | 0 |
| 1996 | 2 | 0 |
| 1997 | 2 | 0 |
| 1998 | 4 | 0 |
| 1999 | 4 | 0 |
| 2000 | 2 | 0 |
| 2001 | 2 | 1 |
| 2002 | 4 | 4 |
| 2003 | 3 | 9 |
| 2004 | 3 | 5 |
| 2005 | 2 | 5 |
| 2006 | 2 | 5 |
| 2007 | 2 | 6 |
| 2008 | 2 | 4 |
| 2009 | 1 | 4 |
| 2010 | 6 | 3 |
| 2011 | 1 | 8 |
| 2012 | 6 | 8 |
| 2013 | 2 | 11 |
| 2014 | 12 | 7 |
| 2015 | 6 | 5 |
| 2016 | 6 | 6 |
| 2017 | 4 | 5 |
| 2018 | 7 | 13 |
| 2019 | 9 | 8 |
| 2020 | 12 | 14 |
| 2021 | 8 | 10 |
| 2022 | 3 | 3 |
| 2023 | 8 | 9 |
| 2024 | 4 | 7 |
| 2025 | 1 | 4 |
| 2026 | 3 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Antimicrobial and anticancer agents28 Apr 2026US 12,612,375 B2Persevere Therapeutics Inc.
- FABP4/5 inhibitors, methods of use and methods of making10 Mar 2026US 12,570,603 B2Celloram Inc.
- Processes for preparing oxathiazin-like compounds27 Jan 2026US 12,534,443 B2Geistlich Pharma AG
- O-substituted serine derivative production method27 May 2025US 12,312,297 B2Chugai Seiyaku Kabushiki Kaisha
- Simplified structural mimetics of AIPS as quorum sensing inhibitors12 Nov 2024US 12,139,464 B2Wisconsin Alumni Research Foundation
- Fabp4/5 inhibitors, methods of use and methods of making14 May 2026US 2026/0132106 A1Celloram Inc.
- Modulators of eukaryotic initiation factor 2b, compositions and methods25 Dec 2025US 2025/0388595 A1Denali Therapeutics Inc.
- O-substituted serine derivative production method21 Aug 2025US 2025/0263365 A1Chugai Seiyaku Kabushiki Kaisha
- Method for selecting additive for suppressing nitrosation reaction, and formulation for suppressing generation of nitroso compounds14 Aug 2025US 2025/0255965 A1Sawai Pharmaceutical Co., Ltd.
- Salts of Ruxolitinib and Crystalline Forms Thereof16 Jan 2025US 2025/0019346 A1Apotex Inc.
Most cited
By later US patents
- Pharmaceutical tramadol salts69US 6,723,343 B2Gruenenthal GmbH · 2004
- Novel naphthalenylalkyl-3H-1,2,3,5-oxathiadiazole 2-oxides useful as antihyperglycemic agents41US 4,897,405 AAmerican Home Products Corporation · 1990
- 1-heterocycle substituted diarylamines38US 6,545,030 B1Warner-Lambert Company · 2003
- Novel benzyl-3H-1,2,3,5-oxathiadiazole 2-oxides useful as antihyperglycemic agents34US 4,895,862 AAmerican Home Products Corporation · 1990
- Antibacterial and antifouling oxathiazines and their oxides34US 5,712,275 AJanssen Pharmaceutica NV · 1998